Silence Therapeutics plc (SLN) short interest & options flow
NASDAQSilence Therapeutics shares are up 127% over the past week, trading at $19.67. The cost to borrow them has risen 75% over the past month, reaching 1.26% as of 22 October. The cost to borrow SLN climbed from 0.16% on 8 October to a peak of 1.53% on 21 October before settling at 1.26%. That move tracks almost exactly with the share price surge…
SLN cost to borrow surges to 1.53%, up 218% in one week amid takeover speculation and clinical momentum.
- Market cap
- $1.19B
- Next earnings
- 10 Nov 2026
Key data as of 3 Nov 2026
Latest signals on SLN
- Cost to Borrow
SLN cost to borrow surges to 1.53%, up 218% in one week amid takeover speculation and clinical momentum.
- Analyst
SLN HC Wainwright downgrades to Neutral, cuts price target 73% to $20 from $75.
SLN news and analysis
RSSNo long-form analysis yet for SLN. Pulse alerts and the live data picture are available on ORTEX.
Open SLN on ORTEX →Want the live picture for SLN?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SLN — free to start on ORTEX.
Sign up for free →Open SLN on ORTEX